Cigna Group $CI Shares Sold by Corient Private Wealth LLC

Key Points

• Corient Private Wealth LLC cut its Cigna Group stake by 25.2% in the fourth quarter, selling 47,461 shares and leaving it with 140,603 shares worth about $38.7 million.
• Wall Street sentiment remains mostly positive: analysts have a Moderate Buy consensus on CI with an average price target of $338.30, though Barclays recently downgraded the stock to equal weight and trimmed its target to $304.
• Cigna reported stronger-than-expected quarterly results, with EPS of $7.79 and revenue of $68.52 billion, and it also paid a quarterly dividend of $1.56 per share, implying a 2.2% yield.

Corient Private Wealth LLC lowered its holdings in Cigna Group (NYSE:CI - Free Report) by 25.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 140,603 shares of the health services provider's stock after selling 47,461 shares during the quarter. Corient Private Wealth LLC owned about 0.05% of Cigna Group worth $38,705,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Brighton Jones LLC increased its stake in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock valued at $1,032,000 after purchasing an additional 318 shares during the last quarter. Sivia Capital Partners LLC lifted its position in shares of Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider's stock worth $384,000 after buying an additional 109 shares during the last quarter. NewEdge Advisors LLC lifted its position in shares of Cigna Group by 4.5% during the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider's stock worth $7,347,000 after buying an additional 958 shares during the last quarter. Treasurer of the State of North Carolina boosted its holdings in shares of Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider's stock valued at $49,204,000 after buying an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. purchased a new position in shares of Cigna Group in the 2nd quarter valued at $163,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on CI shares. Barclays lowered shares of Cigna Group from an "overweight" rating to an "equal weight" rating and cut their price target for the stock from $310.00 to $304.00 in a research note on Tuesday, May 26th. Wall Street Zen upgraded shares of Cigna Group from a "hold" rating to a "buy" rating in a research note on Saturday. Mizuho lifted their target price on Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a research report on Monday, June 8th. Raymond James Financial set a $340.00 target price on Cigna Group in a report on Friday, May 1st. Finally, Royal Bank Of Canada upped their target price on Cigna Group from $333.00 to $337.00 and gave the company an "outperform" rating in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group currently has an average rating of "Moderate Buy" and an average target price of $338.30.

Cigna Group Price Performance

Shares of NYSE:CI opened at $279.63 on Monday. The company has a 50-day simple moving average of $283.79 and a 200-day simple moving average of $278.36. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market capitalization of $73.97 billion, a price-to-earnings ratio of 11.85, a PEG ratio of 1.08 and a beta of 0.28.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business's revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the company posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group's dividend payout ratio (DPR) is 26.45%.

Insider Activity at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the business's stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company's stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company's stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 0.60% of the company's stock.

Cigna Group Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.